CD8+ CTLs are the main effectors that terminate cancer cells, mainly by secreting cytotoxic cytokines including TNF‐α and perforin.[34, 35] TNF‐α and perforin also act as markers of CTL activation. The gene discussed is PRF1; the disease is cancer.